IRIS
MATTIOLI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.483
AS - Asia 43
SA - Sud America 2
Totale 2.528
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.482
CN - Cina 38
SG - Singapore 4
AR - Argentina 1
BR - Brasile 1
IE - Irlanda 1
VN - Vietnam 1
Totale 2.528
Salva come PNG Salva come JPEG
Città #
Genoa 1.708
Vado Ligure 444
Genova 189
Rapallo 116
Bordighera 19
Beijing 14
Singapore 3
Turin 3
Dublin 1
Reconquista 1
Rome 1
São Paulo 1
Tây Ninh 1
Totale 2.501
Salva come PNG Salva come JPEG
Nome #
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 135
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 108
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 107
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 101
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 98
Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma 89
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 89
Altered EEG amplitude coupling correlates to cognitive dysfunction in idiopathic rapid-eye-movement sleep behavior disorder patients 83
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 81
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 79
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 75
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 75
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 71
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 71
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 69
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB) 63
null 63
How can we define a brain health chart? A narrative review and a proposal 62
Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients 59
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 58
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 56
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 55
Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy 53
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in~de~novo Parkinson's Disease 50
Rapid eye movement sleep and epilepsy: exploring interactions and therapeutic prospects 48
Automatic quantification of REM sleep without atonia reliably identifies patients with REM sleep behavior disorder: a possible screening tool? 44
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies 42
Characterization of Sleep Structure and Autonomic Dysfunction in REM Sleep Behavior Disorder 40
Clinical and dopaminergic imaging characteristics of the FARPRESTO cohort of trial‐ready idiopathic rapid eye movement sleep behavior patients 38
Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort 37
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy 37
Electric Source Imaging in Presurgical Evaluation of Epilepsy: An Inter-Analyser Agreement Study 36
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer’s disease and longevity in an Italian population 35
EEG-based Machine Learning Models for the Prediction of Phenoconversion Time and Subtype in iRBD 34
Heart Rate Variability during Sleep-Related Wake Phases in REM Sleep Behavior Disorder 34
Phase and amplitude EEG correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder 33
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 31
Assessment of QT variability in Parkinson's Disease and REM Sleep Behaviour Disorder during REM phase 29
Brain atrophy in idiopathic REM sleep behaviour disorder is a sign of incipient synucleinopathy 29
Brain Hemisphere Dissimilarity, a Self-Supervised Learning Approach for alpha-synucleinopathies prediction with FDG PET 27
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease 25
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 24
Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit? 23
Pitfalls and unmet needs of transition in epilepsy: Understanding the adult neurologist perspective 21
null 20
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study 18
Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study 16
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 15
Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study 14
Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severity 13
Unveiling Cortical Criticality Changes along the Prodromal to the Overt Continuum of Alpha-Synucleinopathy 6
Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis 6
The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New Lexicon 3
Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum 1
Totale 2.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.630
article - articoli 11.147
book - libri 0
conference - conferenze 483
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 2 0 21 8 3 11 5 4 4
2021/2022142 2 0 2 4 13 6 1 18 14 38 20 24
2022/2023138 9 12 4 10 19 13 0 6 25 4 28 8
2023/2024259 8 11 4 39 22 26 37 17 14 18 21 42
2024/20251.221 43 67 58 90 106 158 102 192 72 67 127 139
2025/2026787 334 114 163 176 0 0 0 0 0 0 0 0
Totale 2.629